This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Artery Disease
and you are
between 18 and 99
years old
The phase for this study is not defined.
Show me locations

The purpose

This study sought to compare procedural performance of a new coronary stent generation, that is already available in Germany, with hitherto established current drug-eluting stents.

Provided treatments

  • Device: Synergy Stent
  • Device: Currently common drug-eluting stent (DES)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02881216. The sponsor of the trial is University Hospital Heidelberg and it is looking for 814 volunteers for the current phase.
Official trial title:
Procedural Advantages of a Novel Drug-Eluting Coronary Stent With Ultra-Thin Struts and Bioabsorbable Abluminal Polymer Coating in an All-Comers Registry